Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development
FRANKLIN LAKES, N.J., Feb. 7, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global technology company, today announced the appointment of Amit Bhalla as Vice President, Global Strategy and Development. Mr. Bhalla will join BD in March, 2014 and will report to Vincent A. Forlenza, Chairman, Chief Executive Officer and President.
"I am pleased to welcome Amit to our management team," said Mr. Forlenza. "His extensive experience covering the Medical Technology industry will serve as an asset in this role. I'm confident that his proven expertise will help drive and develop BD's strategy of accelerating growth through innovation, geographic expansion and operating effectiveness to create value for our customers and shareholders."
Mr. Bhalla, 39, will partner with the senior management team in driving the overall development of BD's strategy. The business development and corporate strategy functions will report to him.
He joins BD from Citi, where he served as Director – Equity Research – Life Science Tools/Medical Technology since 2006. Prior to that role, Mr. Bhalla served as Vice President – Equity Research – Emerging Medical Technology at Morgan Stanley, as well as Technical Operations/Research & Development Associate at Johnson & Johnson.
Mr. Bhalla earned his MBA from Carnegie Mellon University at the Tepper School of Business and holds a B.S. in biology from Cornell University.
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research. We are nearly 30,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. For more information, please visit www.bd.com.
SOURCE BD (Becton, Dickinson and Company)
More by this Source
Le test BD Onclarity™ HPV sur le système BD Viper™ LT obtient le marquage CE-IVD
Mar 11, 2014, 10:54 ET
BD to Present at Investor Healthcare Conferences
Feb 25, 2014, 08:00 ET
Healthcare Providers Can Diagnose Group A Strep in Minutes with New Test
Feb 25, 2014, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.